Related Experiment Videos

Renal effects of nadolol in cirrhosis

A Gatta1, D Sacerdoti, C Merkel

  • 1Department of Clinical Medicine, University of Padua, Italy.

Insights

Nadolol treatment in cirrhotics significantly improved renal function and hemodynamics by increasing cardiac output delivery to kidneys. It also suppressed the renin-angiotensin-aldosterone system and increased prostaglandin E2 excretion.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Cirrhosis often leads to altered renal hemodynamics and function.
  • Beta-blockers like nadolol are used in cirrhosis management, but their renal effects require clarification.

Purpose of the Study:

  • To investigate the impact of nadolol on renal hemodynamics, function, and the renin-angiotensin-aldosterone system in cirrhotic patients.

Main Methods:

  • Eighteen cirrhotic patients were treated with nadolol for one month.
  • Measurements included cardiac output, arterial pressure, renal plasma flow, glomerular filtration rate, and urinary PGE2 excretion.

Main Results:

  • Nadolol decreased cardiac output by 25% but increased glomerular filtration rate and renal blood flow proportion.
  • The renin-angiotensin-aldosterone system was suppressed, and urinary PGE2 excretion showed a slight increase.

Conclusions:

  • Nadolol improves renal hemodynamics and function in cirrhotics, independent of arterial pressure changes.
  • Nadolol's effects on renal function are not directly correlated with its impact on the renin-angiotensin-aldosterone system or prostaglandin production.

Related Concept Videos